224 related articles for article (PubMed ID: 28387143)
1. Diabetes control: Incidence of acute myocardial infarction and all-cause mortality among patients with 3-6 years' disease duration.
Reges O; Leibowitz M; Hoshen M; Leventer-Roberts M; Greenland P; Balicer R
Eur J Prev Cardiol; 2017 Jul; 24(10):1083-1092. PubMed ID: 28387143
[TBL] [Abstract][Full Text] [Related]
2. J-curve relationship between long term glycemic control and mortality in diabetic patients with acute myocardial infarction undergoing percutaneous coronary intervention.
Choi IJ; Choo EH; Kim HJ; Lim S; Moon D; Lee KY; Hwang BH; Kim CJ; Park MW; Lee JM; Park CS; Kim HY; Yoo KD; Jeon DS; Chung WS; Kim MC; Jeong MH; Ahn Y; Chang K
Cardiovasc Diabetol; 2021 Dec; 20(1):234. PubMed ID: 34911555
[TBL] [Abstract][Full Text] [Related]
3. Association of Diabetic Status and Glycemic Control With Ischemic and Bleeding Outcomes in Patients With Stable Coronary Artery Disease: The 5-Year CORONOR Registry.
Lemesle G; Meurice T; Tricot O; Lamblin N; Bauters C
J Am Heart Assoc; 2018 May; 7(10):. PubMed ID: 29728374
[TBL] [Abstract][Full Text] [Related]
4. Increased risk of cardiovascular mortality by strict glycemic control (pre-procedural HbA1c < 6.5%) in Japanese medically-treated diabetic patients following percutaneous coronary intervention: a 10-year follow-up study.
Funamizu T; Iwata H; Nishida Y; Miyosawa K; Doi S; Chikata Y; Shitara J; Endo H; Wada H; Naito R; Ogita M; Dohi T; Kasai T; Okazaki S; Isoda K; Miyauchi K; Daida H
Cardiovasc Diabetol; 2020 Feb; 19(1):21. PubMed ID: 32070335
[TBL] [Abstract][Full Text] [Related]
5. Impact of elevated HbA1c on long-term mortality in patients presenting with acute myocardial infarction in daily clinical practice: insights from a 'real world' prospective registry of the Zwolle Myocardial Infarction Study Group.
Hermanides RS; Kennedy MW; Kedhi E; van Dijk PR; Timmer JR; Ottervanger JP; Dambrink JH; Gosselink AM; Roolvink V; Miedema K; Slingerland RJ; Koopmans P; Bilo HJ; van 't Hof AW
Eur Heart J Acute Cardiovasc Care; 2020 Sep; 9(6):616-625. PubMed ID: 31124695
[TBL] [Abstract][Full Text] [Related]
6. Glycated Hemoglobin Variability Is Associated With Adverse Outcomes in Patients With Heart Failure Irrespective of Diabetic Status.
Xu X; Ren QW; Chandramouli C; Ng MY; Tsang CT; Tse YK; Li XL; Liu MY; Wu MZ; Huang JY; Cheang IF; Yang JF; Wang F; Lam CSP; Yiu KH
J Am Heart Assoc; 2024 May; 13(9):e034109. PubMed ID: 38686852
[TBL] [Abstract][Full Text] [Related]
7. The haemoglobin glycation index as predictor of diabetes-related complications in the AleCardio trial.
van Steen SC; Schrieks IC; Hoekstra JB; Lincoff AM; Tardif JC; Mellbin LG; Rydén L; Grobbee DE; DeVries JH;
Eur J Prev Cardiol; 2017 May; 24(8):858-866. PubMed ID: 28186441
[TBL] [Abstract][Full Text] [Related]
8. Optimal glucose, HbA1c, glucose-HbA1c ratio and stress-hyperglycaemia ratio cut-off values for predicting 1-year mortality in diabetic and non-diabetic acute myocardial infarction patients.
Sia CH; Chan MH; Zheng H; Ko J; Ho AF; Chong J; Foo D; Foo LL; Lim PZ; Liew BW; Chai P; Yeo TC; Tan HC; Chua T; Chan MY; Tan JWC; Bulluck H; Hausenloy DJ
Cardiovasc Diabetol; 2021 Oct; 20(1):211. PubMed ID: 34666746
[TBL] [Abstract][Full Text] [Related]
9. Prognostic significance of HbA1c in patients with AMI treated invasively and newly detected glucose abnormalities.
Kowalczyk J; Mazurek M; Zielinska T; Lenarczyk R; Sedkowska A; Swiatkowski A; Sredniawa B; Mencel G; Francuz P; Kalarus Z
Eur J Prev Cardiol; 2015 Jun; 22(6):798-806. PubMed ID: 24618476
[TBL] [Abstract][Full Text] [Related]
10. Severity of Diabetic Retinopathy and the Risk of Future Cerebrovascular Disease, Cardiovascular Disease, and All-Cause Mortality.
Modjtahedi BS; Wu J; Luong TQ; Gandhi NK; Fong DS; Chen W
Ophthalmology; 2021 Aug; 128(8):1169-1179. PubMed ID: 33359888
[TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of diabetes mellitus in patients with atrial fibrillation.
Papazoglou AS; Kartas A; Samaras A; Vouloagkas I; Vrana E; Moysidis DV; Akrivos E; Kotzampasis G; Baroutidou A; Papanastasiou A; Liampas E; Botis M; Karagiannidis E; Stalikas N; Karvounis H; Tzikas A; Giannakoulas G
Cardiovasc Diabetol; 2021 Feb; 20(1):40. PubMed ID: 33573666
[TBL] [Abstract][Full Text] [Related]
12. The Effect of Glycated Hemoglobin and Albumin-Corrected Glycated Serum Protein on Mortality in Diabetic Patients Receiving Continuous Peritoneal Dialysis.
Peng F; Xia X; He F; Li Z; Huang F; Yu X
Perit Dial Int; 2015; 35(5):566-75. PubMed ID: 25395497
[TBL] [Abstract][Full Text] [Related]
13. Mortality and cardiovascular disease burden of uncontrolled diabetes in a registry-based cohort: the ESCARVAL-risk study.
Navarro-Pérez J; Orozco-Beltran D; Gil-Guillen V; Pallares V; Valls F; Fernandez A; Perez-Navarro AM; Sanchis C; Dominguez-Lucas A; Martin-Moreno JM; Redon J; Tellez-Plaza M;
BMC Cardiovasc Disord; 2018 Sep; 18(1):180. PubMed ID: 30176799
[TBL] [Abstract][Full Text] [Related]
14. Impact of insulin therapy on the mortality of acute heart failure patients with diabetes mellitus.
Jang SY; Jang J; Yang DH; Cho HJ; Lim S; Jeon ES; Lee SE; Kim JJ; Kang SM; Baek SH; Cho MC; Choi DJ; Yoo BS; Kim KH; Park SK; Lee HY
Cardiovasc Diabetol; 2021 Sep; 20(1):180. PubMed ID: 34496864
[TBL] [Abstract][Full Text] [Related]
15. All-cause mortality and pharmacological treatment intensity following a high risk screening program for diabetes. A 6.6 year follow-up of the ADDITION study, Denmark.
Lauritzen T; Sandbaek A; Carlsen AH; Borch-Johnsen K
Prim Care Diabetes; 2012 Oct; 6(3):193-200. PubMed ID: 22595031
[TBL] [Abstract][Full Text] [Related]
16. Glycosylated hemoglobin (HbA1c) levels and clinical outcomes in diabetic patients following coronary artery stenting.
Kassaian SE; Goodarzynejad H; Boroumand MA; Salarifar M; Masoudkabir F; Mohajeri-Tehrani MR; Pourhoseini H; Sadeghian S; Ramezanpour N; Alidoosti M; Hakki E; Saadat S; Nematipour E
Cardiovasc Diabetol; 2012 Jul; 11():82. PubMed ID: 22805289
[TBL] [Abstract][Full Text] [Related]
17. The impact of diabetes mellitus and corresponding HbA1c levels on the future risks of cardiovascular disease and mortality: a representative cohort study in Taiwan.
Chen YY; Lin YJ; Chong E; Chen PC; Chao TF; Chen SA; Chien KL
PLoS One; 2015; 10(4):e0123116. PubMed ID: 25874454
[TBL] [Abstract][Full Text] [Related]
18. Glycaemic control and excess risk of major coronary events in persons with type 1 diabetes.
Matuleviciene-Anängen V; Rosengren A; Svensson AM; Pivodic A; Gudbjörnsdottir S; Wedel H; Kosiborod M; Haraldsson B; Lind M
Heart; 2017 Nov; 103(21):1687-1695. PubMed ID: 28710186
[TBL] [Abstract][Full Text] [Related]
19. The effect of change in fasting glucose on the risk of myocardial infarction, stroke, and all-cause mortality: a nationwide cohort study.
Lee G; Kim SM; Choi S; Kim K; Jeong SM; Son JS; Yun JM; Park SM
Cardiovasc Diabetol; 2018 Apr; 17(1):51. PubMed ID: 29626936
[TBL] [Abstract][Full Text] [Related]
20. Mortality associated with less intense risk-factor control among adults with diabetes in the United States.
Saydah SH; Gregg EW; Kahn HS; Ali MK
Prim Care Diabetes; 2018 Feb; 12(1):3-12. PubMed ID: 28797537
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
